Navidea Biopharmaceuticals Incの推定成長EPS Q/Q
Navidea Biopharmaceuticals Incの推定成長EPS Q/Qは何ですか。
Navidea Biopharmaceuticals Incの推定成長EPS Q/Qは-72.73%です。
推定成長EPS Q/Qの定義は何ですか。
期待される四半期ごとのEPS成長率は、過去四半期の業績と比較して、次の四半期の企業EPSの推定増加です。
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NYSEMKTのセクタHealth Careにおける推定成長EPS Q/Qの企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似の推定成長eps q/q
- ObsEva SAの推定成長EPS Q/Qは-73.08%です。
- Mach Natural Resources LPの推定成長EPS Q/Qは-73.08%です。
- Cooper-Standard Incの推定成長EPS Q/Qは-73.03%です。
- Dow Incの推定成長EPS Q/Qは-73.02%です。
- Equity Residential Properties Trustの推定成長EPS Q/Qは-72.86%です。
- Ligand Pharmaceuticalsの推定成長EPS Q/Qは-72.78%です。
- Navidea Biopharmaceuticals Incの推定成長EPS Q/Qは-72.73%です。
- ZIM Integrated Shipping Servicesの推定成長EPS Q/Qは-72.67%です。
- Highwoods Propertiesの推定成長EPS Q/Qは-72.27%です。
- AMTD IDEAの推定成長EPS Q/Qは-72.22%です。
- Amtd International Incの推定成長EPS Q/Qは-72.22%です。
- Liminal Biosciences Incの推定成長EPS Q/Qは-72.22%です。
- Stewart Information Servicesの推定成長EPS Q/Qは-72.11%です。